Gastrointestinal
FDA OKs Rifamycin for Travelers' Diarrhea Caused by Noninvasive E coli
FDA OKs Rifamycin for Travelers' Diarrhea Caused by Noninvasive E coli
Rifamycin's effectiveness was shown in a randomized, placebo-controlled clinical trial during which the drug significantly reduced symptoms of travelers’ diarrhea in adults afflicted with the condition in Guatemala and Mexico. 
Read More >>
Opioid-Induced Constipation
FDA Approves Eravacycline for Adults With Complicated Intra-Abdominal Infections
FDA OKs Eravacycline for Complicated Intra-Abdominal Infections
5 Things Pharmacists Should Know About the Recent Cyclospora Outbreak
Irritable Bowel Syndrome: Newer Drugs Provide Relief
Identifying Gluten-Free Medications to Help Patients with Celiac Disease
The Role of Proton Pump Inhibitors for GI Bleed Prophylaxis in Patients on Dual Antiplatelet Therapy
View more articles >>
Clinical Trials
Diagnosis of Acid Reflux Disease Using Novel Imaging: A Prospective Study
True Short Esophagus in Gastroesophageal Reflux Disease
Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non Erosive Reflux Disease
Influence of Airway Clearance Techniques on GOR in Infants
A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer
Multimedia: Videos
What Lifestyle Interventions Can Pharmacists Recommend to Avoid Stomach Upset?
What Lifestyle Interventions Can Pharmacists Recommend to Avoid Stomach Upset?
How Should Pharmacists Counsel Patients on PPI Use for Heartburn?
How Should Pharmacists Counsel Patients on PPI Use for Heartburn?
How New Agents are Helping Address Clostridium Difficile-Associated Diarrhea Concerns
How New Agents are Helping Address Clostridium Difficile-Associated Diarrhea Concerns
Acid Reflux: More Than a Nuisance
Acid Reflux: More Than a Nuisance